Michael F. Sarosdy

Statistics

Publications

Citations

10.3K

H-Index

Active since

1982

Affiliations

The University of Texas at San Antonio Health Science Center(Current)

West Virginia University

Eastern Virginia Medical School

University of Miami

Wilmington University

Michael F. Sarosdy is an author at The University of Texas at San Antonio Health Science Center specializing in medicine, oncology, and genitourinary oncology.

Publications per year

1982–2015

Publications

Neoadjuvant Chemotherapy plus Cystectomy Compared with Cystectomy Alone for Locally Advanced Bladder Cancer

H. Barton Grossman, Ronald B. Natale, Catherine M. Tangen et al. · New England Journal of Medicine · 2003 · 2.6K citations · Full text

Medicine, Surgery, Urology +12

MAINTENANCE BACILLUS CALMETTE-GUERIN IMMUNOTHERAPY FOR RECURRENT TA, T1 AND CARCINOMA IN SITU TRANSITIONAL CELL CARCINOMA OF THE BLADDER: A RANDOMIZED SOUTHWEST ONCOLOGY GROUP STUDY

Donald L. Lamm, Brent A. Blumenstein, John D. Crissman et al. · The Journal of Urology · 2000 · 1.3K citations

Medicine, Oncology, Urology +11

A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study.

Patrick J. Loehrer, Lawrence H. Einhorn, Paul Elson et al. · Journal of Clinical Oncology · 1992 · 987 citations

Medicine, Oncology, Pharmacology +12

A Randomized Trial of Intravesical Doxorubicin and Immunotherapy with Bacille Calmette–Guérin for Transitional-Cell Carcinoma of the Bladder

Donald L. Lamm, Brent A. Blumenstein, E. David Crawford et al. · New England Journal of Medicine · 1991 · 617 citations · Full text

Medicine, Oncology, Urology +13

Surgical Factors Influence Bladder Cancer Outcomes: A Cooperative Group Report

Harry W. Herr, James R. Faulkner, H. Barton Grossman et al. · Journal of Clinical Oncology · 2004 · 599 citations · Full text

Medicine, Oncology, Surgery +15

1–5 of 54